AGH-192 is a potent and selective, water-soluble, orally bioavailable and brain penetrant full agonist at the 5-HT<sub>7</sub> serotonin receptor of the imidazolylindole family, derived from the older drug AGH-107. In animal tests it showed activity indicative of potential application in the treatment of neuropathic pain.